Long-term bresults of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study

Table 3 Contents and results of radiotherapy (with or without chemotherapy) for postoperative recurrent esophageal cancer in past studies

author	year	No.	regimen	median observation period	2-year survival rate	5-year survival rate
JL Raoul¹²⁾	1995	24	RT† + CDDP*+5-FU	14 months	17.1%	n.a. ‡
K Nemoto¹³⁾	2001	33	RT alone (21) or RT + CDDP+ 5-FU (12)	n.a.	15%	n.a.
Y Nishimura¹¹⁾	2003	13	RT + CDDP+5-FU	9.5 months	19%	n.a.
Y Shioyama¹⁴⁾	2007	82	RT ± chemotherapy	n.a.	22%	11%
K Maruyama¹⁵⁾	2011	23	RT ± chemotherapy	n.a.	31%	24%
Current study	2012	30	RT + CDGP§+ 5-FU	72 months	46.0%	27.0%

†RT: radiotherapy, * CDDP: cisplatin, § CDGP: nedaplatin, # 5-FU: 5-fluorouracil, ‡n.a.: not available.

ISSN: 1471-2407